A phase IIa study of tisotumab vedotin in patients with previously treated recurrent or metastatic cervical cancer : updated analysis of full cervical expansion cohort

Concin, Nicole; Vergote, Ignace; Lassen, Ulrik Niels; Drew, Yvette; Machiels, Jean-Pascal; Arkenau, Hendrik-Tobias; Forster, Martin David; Jones, Robert; Johnson, Melissa Lynne; Slomovitz, Brian M; Spicer, James F.; Cornez, Nathalie; GENNIGENS, Christine; Coleman, Robert L; Windfeld, Kristian; Ghatta, Srinivas; Rangwala, Reshma A.; Hong, David S.

Poster (Scientific congresses and symposiums)

Concin, Nicole; Vergote, Ignace; Lassen, Ulrik Niels et al.

2018 • ESMO Congress 2018

Permalink
https://hdl.handle.net/2268/242180

Files (2)Send to Details Statistics Bibliography Similar publications

Files

Full Text

A phase IIa study of Tisotumab Vedotin in patients ... poster CG.pdf

Publisher postprint (1.38 MB)

Request a copy

Annexes

A phase IIa study of Tisotumab Vedotin in patients ... abstract CG.pdf

Publisher postprint (82.64 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology; tisotumab; metastatic cervical cancer

Disciplines :

Oncology

Author, co-author :

Concin, Nicole; Leuven Cancer Institute

Vergote, Ignace; Leuven Cancer Institute

Lassen, Ulrik Niels

Drew, Yvette

Machiels, Jean-Pascal

Arkenau, Hendrik-Tobias

Forster, Martin David

Jones, Robert

Johnson, Melissa Lynne

Slomovitz, Brian M

More authors (8 more)

Language :

English

Title :

A phase IIa study of tisotumab vedotin in patients with previously treated recurrent or metastatic cervical cancer : updated analysis of full cervical expansion cohort

Publication date :

20 October 2018

Event name :

ESMO Congress 2018

Event place :

Munich, Germany

Event date :

19-23 October 2018

Audience :

International

Available on ORBi :

since 12 December 2019

Statistics

Number of views

110 (4 by ULiège)

Number of downloads

6 (6 by ULiège)

More statistics